ATAI Competitors & Alternatives
Compare ATAI Life Sciences BV with similar stocks in the same industry
Biotechnology
ATAI
Main Stock$5.43
Tradestie Score
63
Market Cap
$1.22B
Revenue Growth
-0.4%
Analyst Upside
+161.1%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.26
|
$2.02B | 54.1 | 57 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.11
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.68
|
$1.97B | - | 60 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.74
|
$1.92B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$105.96
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$73.78
|
$1.90B | 458.4 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.75
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.66
|
$1.81B | - | 62 | Compare |
|
MPLT
MPLT
|
$36.74
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.53
|
$1.78B | - | 59 | Compare |
More ATAI Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry